India’s Ranbaxy Laboratories’ Gets FDA Nod for Cyclobenzaprine HCL

May 15, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, May 15 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration for muscle relaxant cyclobenzaprine hydrochloride tablets, the regulator's website showed.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Asia

Food and Drug Administration (FDA)